Katja Holmgren

Läkare vid Institutionen för medicinska vetenskaper; Dermatologi och venereologi

E-post:: katja.holmgren@uu.se
Besöksadress:: Akademiska sjukhuset, ingång 85, 3 tr
Postadress:: Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA

Ladda ned kontaktuppgifter för Katja Holmgren vid Institutionen för medicinska vetenskaper; Dermatologi och venereologi

Publikationer

Senaste publikationer

Non-invasive Analysis of Skin in Recessive Dystrophic Epidermolysis Bullosa Using High-Frequency Ultrasound: A First Case Report

Wallblom, Karl; Holmgren, Katja; Lundgren, Sigrid; Hoppe, Torborg et al.

Ingår i Acta Dermato-Venereologica, 2026
- DOI för Non-invasive Analysis of Skin in Recessive Dystrophic Epidermolysis Bullosa Using High-Frequency Ultrasound: A First Case Report
- Ladda ner fulltext (pdf) av Non-invasive Analysis of Skin in Recessive Dystrophic Epidermolysis Bullosa Using High-Frequency Ultrasound: A First Case Report
Results of a non-randomized, open-label phase I study evaluating the novel immunomodulatory peptide TCP-25 for treatment of dystrophic epidermolysis bullosa

Wallblom, Karl; Holmgren, Katja; Lundgren, Sigrid; Belfrage, Emma et al.

Ingår i Orphanet Journal of Rare Diseases, 2025
- DOI för Results of a non-randomized, open-label phase I study evaluating the novel immunomodulatory peptide TCP-25 for treatment of dystrophic epidermolysis bullosa
- Ladda ner fulltext (pdf) av Results of a non-randomized, open-label phase I study evaluating the novel immunomodulatory peptide TCP-25 for treatment of dystrophic epidermolysis bullosa

Alla publikationer

Artiklar i tidskrift

Non-invasive Analysis of Skin in Recessive Dystrophic Epidermolysis Bullosa Using High-Frequency Ultrasound: A First Case Report

Wallblom, Karl; Holmgren, Katja; Lundgren, Sigrid; Hoppe, Torborg et al.

Ingår i Acta Dermato-Venereologica, 2026
- DOI för Non-invasive Analysis of Skin in Recessive Dystrophic Epidermolysis Bullosa Using High-Frequency Ultrasound: A First Case Report
- Ladda ner fulltext (pdf) av Non-invasive Analysis of Skin in Recessive Dystrophic Epidermolysis Bullosa Using High-Frequency Ultrasound: A First Case Report
Results of a non-randomized, open-label phase I study evaluating the novel immunomodulatory peptide TCP-25 for treatment of dystrophic epidermolysis bullosa

Wallblom, Karl; Holmgren, Katja; Lundgren, Sigrid; Belfrage, Emma et al.

Ingår i Orphanet Journal of Rare Diseases, 2025
- DOI för Results of a non-randomized, open-label phase I study evaluating the novel immunomodulatory peptide TCP-25 for treatment of dystrophic epidermolysis bullosa
- Ladda ner fulltext (pdf) av Results of a non-randomized, open-label phase I study evaluating the novel immunomodulatory peptide TCP-25 for treatment of dystrophic epidermolysis bullosa